×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANIK – anika therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANIK
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
7/15
04:01 pm
anik
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
Low
Report
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
6/5
05:00 pm
anik
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/3
08:05 pm
anik
President of Anika Therapeutics Picks Up 51% More Stock [Yahoo! Finance]
Low
Report
President of Anika Therapeutics Picks Up 51% More Stock [Yahoo! Finance]
4/30
11:27 am
anik
Bullish On Anika Therapeutics's Pullback As Integrity Scales [Seeking Alpha]
Low
Report
Bullish On Anika Therapeutics's Pullback As Integrity Scales [Seeking Alpha]
4/29
07:57 am
anik
Anika Reports First Quarter 2026 Financial Results [Yahoo! Finance]
High
Report
Anika Reports First Quarter 2026 Financial Results [Yahoo! Finance]
4/29
07:05 am
anik
Anika Reports First Quarter 2026 Financial Results
High
Report
Anika Reports First Quarter 2026 Financial Results
4/21
12:19 pm
anik
Anika (ANIK) Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Low
Report
Anika (ANIK) Q2 2025 Earnings Call Transcript [Globe and Mail, The (Toronto, Canada)]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
7/14
05:00 pm
anik
Form 8-K Anika Therapeutics, Inc. For: Jul 10
Low
Report
Form 8-K Anika Therapeutics, Inc. For: Jul 10
6/23
04:30 pm
anik
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Fischetti Gary P
Low
Report
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Fischetti Gary P
6/23
04:30 pm
anik
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: CONLEY SHERYL L
Low
Report
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: CONLEY SHERYL L
6/23
04:30 pm
anik
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: HENNEMAN JOHN B III
Low
Report
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: HENNEMAN JOHN B III
6/23
04:30 pm
anik
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Richard Stephen
Low
Report
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Richard Stephen
6/23
04:30 pm
anik
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Capper Joseph H
Low
Report
Form 4 Anika Therapeutics, Inc. For: Jun 18 Filed by: Capper Joseph H
6/23
04:06 pm
anik
Form 8-K Anika Therapeutics, Inc. For: Jun 18
Low
Report
Form 8-K Anika Therapeutics, Inc. For: Jun 18
6/8
09:26 am
anik
Form DEFA14A Anika Therapeutics, Inc.
Low
Report
Form DEFA14A Anika Therapeutics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/24
Q3/2019 9/30/2019 EPS 0.640 ZacksConsensus 0.410 ActVsEst 0.230 - Beat
35.2%
7/24 Q2/2019 6/30/2019 EPS 0.670 ZacksConsensus 0.420 ActVsEst 0.250 - Beat 29.0%
4/8 Anika Therapeutics beefs up liquidity amid COVID-19 disruptions [Seeking Alpha] 9.0%
3/24 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.9%
4/28 Form 4 Anika Therapeutics, Inc. For: Apr 26 Filed by: Blanchard Cheryl R 7.9%
5/3 Anika Therapeutics, Inc. 2019 Q1 - Results - Earnings Call Slides [Seeking Alpha] 5.9%
1/6 Anika Therapeutics to Acquire Parcus Medical and Arthrosurface 4.6%
4/22 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.6%
4/27 Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer 4.3%
7/25 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. 3.2%
7/24 Q2/2019 6/30/2019 EPS 0.670 ZacksConsensus 0.420 ActVsEst 0.250 - Beat 29.0%
4/8 Anika Therapeutics beefs up liquidity amid COVID-19 disruptions [Seeking Alpha] 9.0%
3/24 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.9%
4/28 Form 4 Anika Therapeutics, Inc. For: Apr 26 Filed by: Blanchard Cheryl R 7.9%
5/3 Anika Therapeutics, Inc. 2019 Q1 - Results - Earnings Call Slides [Seeking Alpha] 5.9%
1/6 Anika Therapeutics to Acquire Parcus Medical and Arthrosurface 4.6%
4/22 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.6%
4/27 Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer 4.3%
7/25 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. 3.2%
TOP News Decliners
3/13
Form 8-K/A Anika Therapeutics, Inc. For: Feb 03
-16.2%
3/18 Form SEC STAFF LETTER Anika Therapeutics, Inc. -11.5%
3/6 Form 3 Anika Therapeutics, Inc. For: Mar 04 Filed by: Colleran David -9.4%
4/29 Form DEF 14A Anika Therapeutics, Inc. For: Jun 16 -7.3%
2/20 Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.0%
3/17 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.8%
1/29 Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer -5.4%
4/27 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock. -4.7%
7/26 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.5%
7/30 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at TheStreet from a "c" rating to a "b-" rating. -4.4%
3/18 Form SEC STAFF LETTER Anika Therapeutics, Inc. -11.5%
3/6 Form 3 Anika Therapeutics, Inc. For: Mar 04 Filed by: Colleran David -9.4%
4/29 Form DEF 14A Anika Therapeutics, Inc. For: Jun 16 -7.3%
2/20 Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.0%
3/17 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.8%
1/29 Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer -5.4%
4/27 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock. -4.7%
7/26 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.5%
7/30 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at TheStreet from a "c" rating to a "b-" rating. -4.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: